Amedeo Smart

Free Medical Literature Service

 

Amedeo

Venous Thrombosis
  Free Subscription

Articles published in
Ann Intern Med
    January 2024
  1. WATSON NW, Carroll BJ, Krawisz A, Schmaier A, et al
    Trends in Discharge Rates for Acute Pulmonary Embolism in U.S. Emergency Departments.
    Ann Intern Med. 2024 Jan 30. doi: 10.7326/M23-2442.
    >> Share

    December 2023
  2. WEITZ HH, Merli GJ, Benesch C
    Annals Consult Guys - Surgery After Thromboembolic Stroke.
    Ann Intern Med. 2023;176:eW220025.
    >> Share

    October 2023
  3. PARKS AL, Stevens SM
    In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation.
    Ann Intern Med. 2023;176:JC118.
    >> Share

    June 2023
  4. KHAN F, Coyle D, Thavorn K, van Katwyk S, et al
    Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study.
    Ann Intern Med. 2023 Jun 27. doi: 10.7326/M22-3559.
    >> Share

    May 2023
  5. ROUSSEL M, Bloom B, Taalba M, Choquet C, et al
    Temporal Trends in the Use of Computed Tomographic Pulmonary Angiography for Suspected Pulmonary Embolism in the Emergency Department : A Retrospective Analysis.
    Ann Intern Med. 2023 May 23. doi: 10.7326/M22-3116.
    >> Share

    April 2023
  6. DELOUGHERY TG
    In symptomatic isolated DVT, 12 wk vs. 6 wk of rivaroxaban reduced recurrent VTE at 24 mo.
    Ann Intern Med. 2023;176:JC42.
    >> Share

    November 2022

  7. Correction: Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban and Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2022;175:1627-1628.
    >> Share

    September 2022
  8. WEITZ HH, Merli GJ
    Annals Consult Guys - Standardizing Venous Thromboembolism Prophylaxis in the Setting of Orthopedic Surgery.
    Ann Intern Med. 2022;175:CG1.
    >> Share

    August 2022
  9. BOTTON J, Jabagi MJ, Bertrand M, Baricault B, et al
    Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
    Ann Intern Med. 2022 Aug 23. doi: 10.7326/M22-0988.
    >> Share

  10. KANJEE Z, Freed JA, Carroll BJ, Reynolds EE, et al
    How Would You Treat This Patient With Pulmonary Embolism? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2022 Aug 9. doi: 10.7326/M22-0989.
    >> Share

    June 2022
  11. MITHOOWANI S, Lim W
    Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis.
    Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0039.
    >> Share

  12. SMITH CA, Barnes GD
    Web Exclusive. Annals for Hospitalists Inpatient Notes - Venous Thromboembolism Prophylaxis in COVID-19: Making Sense of the Evidence.
    Ann Intern Med. 2022;175:HO2-HO3.
    >> Share

    April 2022
  13. CARRIER M, Le Gal G
    Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.
    Ann Intern Med. 2022;175:W43-W44.
    >> Share

  14. WESTAFER LM, Vinson DR
    Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.
    Ann Intern Med. 2022;175:W43.
    >> Share

  15. GOUMENIOUK N, Lang E
    In suspected PE, YEARS rule + D-dimer was noninferior to D-dimer alone to rule out PE.
    Ann Intern Med. 2022;175:JC43.
    >> Share

    February 2022
  16. HVIID A, Hansen JV, Thiesson EM, Wohlfahrt J, et al
    Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Ann Intern Med. 2022 Feb 1. doi: 10.7326/M21-2452.
    >> Share

  17. CENTOR RM, Le Gal G
    Annals On Call - The Risk for Subsegmental Pulmonary Embolism.
    Ann Intern Med. 2022 Feb 1:OC1. doi: 10.7326/A21-0004.
    >> Share

  18. BIKDELI B, Garcia DA
    In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d.
    Ann Intern Med. 2022 Feb 1. doi: 10.7326/J21-0019.
    >> Share

  19. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Unprovoked Venous Thromboembolism: Challenging Questions.
    Ann Intern Med. 2022;175:CG1.
    >> Share

  20. KHAN F, Tritschler T, Le Gal G, Fergusson DA, et al
    Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism.
    Ann Intern Med. 2022;175:W14.
    >> Share

  21. BROUILLARD P, LeLorier J
    Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism.
    Ann Intern Med. 2022;175:W14.
    >> Share

  22. CHAIRETI R
    In patients hospitalized for COPD exacerbation, a PE diagnostic strategy + usual care did not improve outcomes.
    Ann Intern Med. 2022;175:JC19.
    >> Share

    January 2022
  23. BANNOW BS
    In acute PE, triage for home treatment using the Hestia rule vs. sPESI was noninferior for 30-d clinical outcomes.
    Ann Intern Med. 2022;175:JC7.
    >> Share

    December 2021
  24. BROTMAN DJ
    Higher D-Dimer Thresholds for Excluding Pulmonary Embolism: No Free Lunch?
    Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-4295.
    >> Share

  25. STALS MAM, Takada T, Kraaijpoel N, van Es N, et al
    Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysis.
    Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-2625.
    >> Share

  26. DAWWAS GK, Leonard CE, Lewis JD, Cuker A, et al
    Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data.
    Ann Intern Med. 2021 Dec 7. doi: 10.7326/M21-0717.
    >> Share

    November 2021
  27. LE GAL G, Kovacs MJ, Bertoletti L, Couturaud F, et al
    Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.
    Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981.
    >> Share

  28. MUSEY PI, Hunter BR
    Black patients with COVID-19 had increased risk for 30-d mortality, PE, and other adverse outcomes vs. White patients.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    >> Share

    September 2021

  29. Summary for Patients: Bleeding Risk During Extended Anticoagulant Therapy for Venous Thromboembolism.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/P21-0009.
    >> Share

  30. KHAN F, Tritschler T, Kimpton M, Wells PS, et al
    Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/M21-1094.
    >> Share

    December 2020
  31. EPELBAUM O
    Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.
    Ann Intern Med. 2020;173:1029-1030.
    >> Share

  32. WICHMANN D
    Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.
    Ann Intern Med. 2020;173:1030.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016